Sacerdoti, David
 Distribuzione geografica
Continente #
NA - Nord America 3.220
EU - Europa 2.754
AS - Asia 1.183
OC - Oceania 18
SA - Sud America 12
AF - Africa 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.192
Nazione #
US - Stati Uniti d'America 3.205
CN - Cina 1.041
GB - Regno Unito 858
FR - Francia 547
IE - Irlanda 520
UA - Ucraina 261
SE - Svezia 225
IT - Italia 136
DE - Germania 99
VN - Vietnam 93
FI - Finlandia 51
AU - Australia 18
CA - Canada 15
RU - Federazione Russa 14
BE - Belgio 11
HK - Hong Kong 10
TR - Turchia 10
IN - India 6
BR - Brasile 5
NL - Olanda 5
NO - Norvegia 4
HU - Ungheria 3
ID - Indonesia 3
JP - Giappone 3
PE - Perù 3
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
RO - Romania 2
SA - Arabia Saudita 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 7.192
Città #
Southend 840
Jacksonville 785
Chandler 548
Dublin 518
Ashburn 263
Lawrence 261
Princeton 261
Wilmington 219
Beijing 179
Jinan 119
Ann Arbor 80
Dong Ket 79
Shenyang 78
Sindelfingen 59
Nanjing 52
Ningbo 51
Helsinki 50
Tianjin 44
Changsha 43
Haikou 41
Hebei 41
Seattle 33
Zhengzhou 32
Hangzhou 31
Taizhou 31
Fairfield 30
Nanchang 30
Verona 30
Houston 26
Norwalk 24
Taiyuan 24
Guangzhou 22
Milan 22
New York 22
Redwood City 22
Lanzhou 20
San Francisco 20
Washington 20
Redmond 15
Jiaxing 14
San Diego 13
Woodbridge 13
Fuzhou 12
Brussels 11
Bonndorf 9
Legnago 9
Toronto 9
Des Moines 8
Melbourne 8
Canberra 6
Chicago 6
Brescia 5
Clearwater 4
Hong Kong 4
Kemerovo 4
Riva 4
São Paulo 4
Central 3
Falls Church 3
Lima 3
London 3
Montesilvano Marina 3
Rome 3
Saint Petersburg 3
Trento 3
Vittuone 3
Yicheng 3
Alessandria 2
Amsterdam 2
Bologna 2
Changle 2
Chaoyang 2
Genova 2
Montréal 2
Nomi 2
Oslo 2
Ponte San Pietro 2
Sesto Calende 2
Singapore 2
Sydney 2
Tokyo 2
Vienna 2
Zanjan 2
Absecon 1
Almere Stad 1
Amman 1
Andover 1
Arcole 1
Athens 1
Atlanta 1
Belgrade 1
Berlin 1
Bishkek 1
Boston 1
Bratislava 1
Brno 1
Budapest 1
Cairo 1
Cambridge 1
Chisinau 1
Totale 5.287
Nome #
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 93
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 92
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 78
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 74
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 72
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 57
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 55
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 54
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 54
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 51
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 50
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 50
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 48
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 48
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 48
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 47
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 47
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 46
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 45
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 44
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 43
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 43
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 43
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 42
Vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler. 42
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 42
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 42
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 41
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 41
Renal function in congestive heart failure. 41
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 41
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 41
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 40
Drugs in the prevention of rebleeding in cirrhosis 40
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 40
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 40
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 40
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 40
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 39
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 39
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 39
A MULTICENTER CONTROLLED-STUDY COMPARING BETA-BLOCKERS AND BETA-BLOCKERS PLUS NITRODERIVATIVES IN THE PRIMARY PROPHYLAXIS OF 1ST VARICEAL BLEEDING IN CIRRHOSIS - INTERIM ANALYSIS 39
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices. 39
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 39
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 39
Agreement and predictive validity of neurophysiological, psychometric, and psychophysical indices of hepatic encephalopathy 39
La profilassi primaria dell'emorragia da rottura di varici esofagee 38
L'ipertensione portale 38
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 38
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 38
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 37
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 37
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 37
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 37
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 37
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 36
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) 36
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 36
Role of HO/CO in the Control of Peripheral Circulation in Humans 36
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 36
Effetto protettivo del corm-3 nei confronti del danno da ischemia-riperfusione in un modello sperimentale porcino 35
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 35
Renal effects of nadolol in patients with liver cirrhosis 34
Effetti dell'Iloprost sull'emodinamica renale, sul metabolismo intrarenale del sodio e sul sistema renina-angiotensina-aldosterone. 34
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 34
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 34
L'eco-Doppler dei vasi splancnici nella cirrosi 34
Alteration in endothelial function in cirrhosis 34
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 34
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 34
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 34
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) ON NON-OBESE DIABETES: PREVALENCE AND RELATIONSHIP WITH DOPPLER HEMODINAMIC ALTERATIONS, LEPTIN, INFLAMMATION AND OXIDATIVE STRESS 34
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells 34
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 33
Alterazioni epatiche in corso di scompenso cardiaco 33
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 33
null 33
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 33
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 32
Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats 32
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 32
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 32
Il paradigma di Stenberg in pazienti cirrotici senza encefalopatia epatica clinicamente manifesta 31
Impaired sodium and water excretion in preascitic cirrhosis: renal mechanisms. 31
Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis 31
Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells 31
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 31
Imaging e valutazione emodinamica nella diagnostica epatologica 31
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment 31
Clinical significance of data obtained from hepatic vein catheterization in the prognostic evaluation of patients with cirrhosis with esophageal varices. 30
Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity 30
Prevenzione della recidiva emorragica da rottura di varici esofagee nel cirrotico 30
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 30
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 30
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins 30
Differences between acute and chronic effects of nadolol on portal hypertension in patients with cirrhosis: a pathophysiological interpretation 30
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 30
PGE2 renali e metabolismo del sodio e dell'acqua nella cirrosi epatica anascitica 29
Prevenzione della recidiva emorragica da rottura di varici esofagee nel cirrotico. 29
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 29
Totale 4.005
Categoria #
all - tutte 36.002
article - articoli 27.253
book - libri 399
conference - conferenze 6.425
curatela - curatele 0
other - altro 213
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.712
Totale 72.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 1 3 3
2019/2020743 2 6 3 2 6 6 3 258 16 46 63 332
2020/20211.861 248 177 60 343 261 294 23 9 11 8 329 98
2021/20221.594 104 209 11 23 111 21 54 115 108 115 238 485
2022/20232.479 282 156 346 236 378 700 15 101 162 10 49 44
2023/2024820 52 86 86 113 70 198 129 77 2 7 0 0
Totale 7.515